BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35073575)

  • 1. Monocyte miRNAs Are Associated With Type 2 Diabetes.
    Parker DC; Wan M; Lohman K; Hou L; Nguyen AT; Ding J; Bertoni A; Shea S; Burke GL; Jacobs DR; Post W; Corcoran D; Hoeschele I; Parks JS; Liu Y
    Diabetes; 2022 Apr; 71(4):853-861. PubMed ID: 35073575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients.
    Collares CV; Evangelista AF; Xavier DJ; Rassi DM; Arns T; Foss-Freitas MC; Foss MC; Puthier D; Sakamoto-Hojo ET; Passos GA; Donadi EA
    BMC Res Notes; 2013 Nov; 6():491. PubMed ID: 24279768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating serum microRNAs including senescent miR-31-5p are associated with incident fragility fractures in older postmenopausal women with type 2 diabetes mellitus.
    Heilmeier U; Hackl M; Schroeder F; Torabi S; Kapoor P; Vierlinger K; Eiriksdottir G; Gudmundsson EF; Harris TB; Gudnason V; Link TM; Grillari J; Schwartz AV
    Bone; 2022 May; 158():116308. PubMed ID: 35066213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 Diabetes Mellitus and its comorbidity, Alzheimer's disease: Identifying critical microRNA using machine learning.
    Alamro H; Bajic V; Macvanin MT; Isenovic ER; Gojobori T; Essack M; Gao X
    Front Endocrinol (Lausanne); 2022; 13():1084656. PubMed ID: 36743910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of microRNAs targeting type-2 diabetes susceptibility genes in peripheral blood of patients and predisposed individuals.
    Kokkinopoulou I; Maratou E; Mitrou P; Boutati E; Sideris DC; Fragoulis EG; Christodoulou MI
    Endocrine; 2019 Nov; 66(2):226-239. PubMed ID: 31559537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA Changes Up to 24 h following Induced Hypoglycemia in Type 2 Diabetes.
    Ramanjaneya M; Bettahi I; Pawar K; Halabi NM; Moin ASM; Sathyapalan T; Abou-Samra AB; Atkin SL; Butler AE
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization.
    Ortega FJ; Mercader JM; Moreno-Navarrete JM; Rovira O; Guerra E; Esteve E; Xifra G; Martínez C; Ricart W; Rieusset J; Rome S; Karczewska-Kupczewska M; Straczkowski M; Fernández-Real JM
    Diabetes Care; 2014; 37(5):1375-83. PubMed ID: 24478399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human pancreatic islet microRNAs implicated in diabetes and related traits by large-scale genetic analysis.
    Taylor HJ; Hung YH; Narisu N; Erdos MR; Kanke M; Yan T; Grenko CM; Swift AJ; Bonnycastle LL; Sethupathy P; Collins FS; Taylor DL
    Proc Natl Acad Sci U S A; 2023 Feb; 120(7):e2206797120. PubMed ID: 36757889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A data-driven biocomputing pipeline with meta-analysis on high throughput transcriptomics to identify genome-wide miRNA markers associated with type 2 diabetes.
    De Silva K; Demmer RT; Jönsson D; Mousa A; Forbes A; Enticott J
    Heliyon; 2022 Feb; 8(2):e08886. PubMed ID: 35169647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum miRNA Signatures Are Indicative of Skeletal Fractures in Postmenopausal Women With and Without Type 2 Diabetes and Influence Osteogenic and Adipogenic Differentiation of Adipose Tissue-Derived Mesenchymal Stem Cells In Vitro.
    Heilmeier U; Hackl M; Skalicky S; Weilner S; Schroeder F; Vierlinger K; Patsch JM; Baum T; Oberbauer E; Lobach I; Burghardt AJ; Schwartz AV; Grillari J; Link TM
    J Bone Miner Res; 2016 Dec; 31(12):2173-2192. PubMed ID: 27345526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated HDL-bound miR-181c-5p level is associated with diabetic vascular complications in Australian Aboriginal people.
    Morrison KR; Solly EL; Shemesh T; Psaltis PJ; Nicholls SJ; Brown A; Bursill CA; Tan JTM
    Diabetologia; 2021 Jun; 64(6):1402-1411. PubMed ID: 33651121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From Euglycemia to Recent Onset of Type 2 Diabetes Mellitus: A Proof-of-Concept Study on Circulating microRNA Profiling Reveals Distinct, and Early microRNA Signatures.
    Greco M; Mirabelli M; Salatino A; Accattato F; Aiello V; Brunetti FS; Chiefari E; Pullano SA; Fiorillo AS; Foti DP; Brunetti A
    Diagnostics (Basel); 2023 Jul; 13(14):. PubMed ID: 37510186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis.
    van de Bunt M; Gaulton KJ; Parts L; Moran I; Johnson PR; Lindgren CM; Ferrer J; Gloyn AL; McCarthy MI
    PLoS One; 2013; 8(1):e55272. PubMed ID: 23372846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma microRNA Profiling in Type 2 Diabetes Mellitus: A Pilot Study.
    Tonyan ZN; Barbitoff YA; Nasykhova YA; Danilova MM; Kozyulina PY; Mikhailova AA; Bulgakova OL; Vlasova ME; Golovkin NV; Glotov AS
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole blood microRNA levels associate with glycemic status and correlate with target mRNAs in pathways important to type 2 diabetes.
    Mononen N; Lyytikäinen LP; Seppälä I; Mishra PP; Juonala M; Waldenberger M; Klopp N; Illig T; Leiviskä J; Loo BM; Laaksonen R; Oksala N; Kähönen M; Hutri-Kähönen N; Raitakari O; Lehtimäki T; Raitoharju E
    Sci Rep; 2019 Jun; 9(1):8887. PubMed ID: 31222113
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Sánchez-Ceinos J; Rangel-Zuñiga OA; Clemente-Postigo M; Podadera-Herreros A; Camargo A; Alcalá-Diaz JF; Guzmán-Ruiz R; López-Miranda J; Malagón MM
    Mol Ther Nucleic Acids; 2021 Mar; 23():1035-1052. PubMed ID: 33614249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes induces dysregulation of microRNAs associated with survival, proliferation and self-renewal in cardiac progenitor cells.
    Purvis N; Kumari S; Chandrasekera D; Bellae Papannarao J; Gandhi S; van Hout I; Coffey S; Bunton R; Sugunesegran R; Parry D; Davis P; Williams MJA; Bahn A; Katare R
    Diabetologia; 2021 Jun; 64(6):1422-1435. PubMed ID: 33655378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transcriptional markers associated with clinical complications in Type 1 and Type 2 diabetes mellitus.
    Massaro JD; Polli CD; Costa E Silva M; Alves CC; Passos GA; Sakamoto-Hojo ET; Rodrigues de Holanda Miranda W; Bispo Cezar NJ; Rassi DM; Crispim F; Dib SA; Foss-Freitas MC; Pinheiro DG; Donadi EA
    Mol Cell Endocrinol; 2019 Jun; 490():1-14. PubMed ID: 30926524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating microRNAs as clinically useful biomarkers for Type 2 Diabetes Mellitus: miRNomics from bench to bedside.
    Grieco GE; Besharat ZM; Licata G; Fignani D; Brusco N; Nigi L; Formichi C; Po A; Sabato C; Dardano A; Natali A; Dotta F; Sebastiani G; Ferretti E
    Transl Res; 2022 Sep; 247():137-157. PubMed ID: 35351622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of Inflammation, Oxidative Stress, and Glucose Metabolism-Related Genes and miRNAs in Visceral Adipose Tissue of Women with Type 2 Diabetes Mellitus.
    Wróblewski A; Strycharz J; Oszajca K; Czarny P; Świderska E; Matyjas T; Zieleniak A; Rucińska M; Pomorski L; Drzewoski J; Śliwińska A; Szemraj J
    Med Sci Monit; 2023 Jul; 29():e939299. PubMed ID: 37422695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.